Det är följande vetenskapliga artiklar som ligger till grund för det Socialstyrelsen försäkringsmedicinska beslutstöd när det gäller bröstcancer. Vårdprogrammen saknas för de fick inte plats.
Referenser
Sickness Absence and Disability Pension After Breast Cancer Diagnosis: A 5-Year Nationwide Cohort Study Kvillemo P, Mittendorfer-rutz E, Bränström R, Nilsson K, Alexanderson K
Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2017;35(18):2044-2052
Sickness absence and disability pension following breast cancer – A population-based matched cohort study Marie Høyer Lundh, Claudia Lampic, Karin Nordin, Johan Ahlgren, Leif Bergkvist, Mats Lambe, Anders Berglund, The Breast Volume 23, Issue 6, December 2014, Pages 844-851
Return to work after breast cancer-an exploratory systematic literature review Wennman-larsen A, Petersson Lm, Alexanderson K
EUROPEAN JOURNAL OF PUBLIC HEALTH 2010;59-60
Predictors of return to work ten months after primary breast cancer surgery Johnsson A, Fornander T, Rutqvist Le, Vaez M, Alexanderson K, Olsson M ACTA ONCOLOGICA 2009;48(1):93-8
How common is fatigue in disease free breast cancer survivors? A systematic review of the literature, Minton et al.Breast cancer res. Treat. 2008
Late effects of breast cancer treatment and potentials for rehabilitation. Ewertz M and Bonde Jensen A, Acta Oncologica 2011; 50: 187-193
A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Ono, M, Ogilvie, JM, Wilson, JS, Green, HJ, Chambers, SK, Ownsworth, T, et al. Frontiers in oncology. 2015; 5:59.
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF, J Clin Oncol. 2005;23(31):8025-32
Arm morbidity and sick leave among working women shortly after breast cancer surgery Wennman-Larsen A, Olsson M, Alexanderson K, Nilsson Mi, Petersson Lm European journal of oncology nursing : the official journal of European Oncology Nursing Society 2013;17(1):101-6
Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study. Ganz PA, Petersen L, Bower JE, Crespi CM., J Clin Oncol. 2016 Mar 10;34(8):816-24).
Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Lee, PE, Tierney, MC, Wu, W, Pritchard, KI, Rochon, PA. Breast cancer research and treatment. 2016; 158(3):407-20.
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Susan F. Dent, Rania Gaspo, Michelle Kissner, Kathleen I. Pritchard. Breast Cancer Res Treat (2011) 126:295–310.
Functional disability and aromatase inhibitor-associated arthralgia in breast cancer survivors. C. F. Friedman, D. Bruner, S. Xie, K. Desai, C. T. Stricker, A. DeMichele, J. Mao; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. J Clin Oncol 28:15s, 2010 (suppl; abstr 9156).
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management
Stéphanie Gaillard and Vered Stearns* Gaillard and Stearns Breast Cancer Research 2011, 13:205
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study. Laroche F, Perrot S, Medkour T, Cottu PH, Pierga JY, Lotz JP, Beerblock K, Tournigand C, Chauvenet L, Bouhassira D, Coste J.
PLoS One. 2017 Nov 8;12(11):e0187165. doi: 10.1371/journal.pone.0187165. eCollection 2017
Estrogen and cognitive functioning in women. Sherwin BB. Endocr Rev 2003;24:133–51.
Short- And Long-Term Effects of Breast Cancer Diagnosis and Adjuvant Endocrine Treatment on Life Satisfaction Anna Skördåker1, Anna von Wachenfeldt2, Elisabet Lidbrink 3, Johanna Stjärnfeldt4 , Aina Johnsson 5 American Research Journal of Nursing Original Article ISSN 2379-2922 Volume 1, Issue 3, 2015 www.arjonline.org 13
Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis.
Underwood EA1,2,3, Rochon PA1,4,5,6, Moineddin R7, Lee PE8, Wu W4, Pritchard KI5,3,9, Tierney MC10,11,12,13. Breast Cancer Res Treat. 2018 Apr;168(2):299-310. doi: 10.1007/s10549-017-4627-4. Epub 2017 Dec 20.
Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress.
Andreano JM1, Waisman J, Donley L, Cahill L. Psychooncology. 2012 Oct;21(10):1091-8. doi: 10.1002/pon.2006. Epub 2011 Aug 22.
Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. CS, Struchen M, Hahn S, Franzen K. Varney NR, Syrop C, Kubu J Assist Reprod Genet 1993;10:53–7.
Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Newton C, Slota D, Yuzpe AA, Tummon IS. Fertil Steril 1996;5:1253–5.
Anxiety and mood disorders associated with gonadotropin-releasing hormone agonists therapy. Warnock JK, Bundren JC. Psychopharmacol Bull 1997;33:311–6.
Depressive symptoms associated with gonadotropin-releasing hormone agonists. Warnock JK, Bundren JC, Morris DW. Depress Anxiety 1998;7:171–7.
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life Palomba, S., Orio, F. Jr., Russo, T., Falbo, A., Amati, A., Zullo, F FERTILITY AND STERILITY, VOL. 82, NO. 2, AUGUST 2004
Improved survival in metastatic breast cancer 1985-2016
Marie Sundquist, Lars Brudin, Goran Tejler. The Breast 31 (2017) 46-50
SBU rapport Bröstcancer och rehabilitering 2010.
Socialstyrelsen. Nationella riktlinjer för bröst-, kolorektal- och prostatacancer. 2014
Nationellt vårdprogram för bröstcancer 2018
Vårdguiden: https://www.1177.se
Aina Johnsson
Kurator och forskare som kan svara på frågor om sjukförsäkring, försäkringar, fonder/bidrag, patienträttigheter, arbetsplatsfrågor och relationer.